Singapore markets close in 3 hours 48 minutes
Straits Times Index
3,316.66 +8.76 (+0.26%) Nikkei
39,116.16 +499.06 (+1.29%) Hang Seng
18,930.02 -265.58 (-1.38%) FTSE 100
8,370.33 -46.12 (-0.55%) Bitcoin USD
69,400.06 -286.81 (-0.41%) CMC Crypto 200
1,514.81 -11.61 (-0.76%)
DCPH Jun 2024 20.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 09:57AM EDT. Market open.
| Previous close | 5.60 |
| Open | 5.50 |
| Bid | 0.00 |
| Ask | 0.00 |
| Strike | 20.00 |
| Expiry date | 2024-06-21 |
| Day's range | 5.30 - 5.60 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
ZacksHere's What Key Metrics Tell Us About Deciphera Pharmaceuticals (DCPH) Q1 Earnings
While the top- and bottom-line numbers for Deciphera Pharmaceuticals (DCPH) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
ZacksDeciphera Pharmaceuticals, Inc. (DCPH) Reports Q1 Loss, Misses Revenue Estimates
Deciphera Pharmaceuticals (DCPH) delivered earnings and revenue surprises of 5.45% and 2.15%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
ZacksThe Zacks Analyst Blog Highlights Gilead Sciences, GSK, Deciphera, Bristol Myers and Editas Medicine
Gilead Sciences, GSK, Deciphera, Bristol Myers and Editas Medicine are included in this Analyst Blog.
© 2024 Yahoo. All rights reserved.